Related Experiment Video
Updated: Feb 2, 2026

Precise Cellular Ablation Approach for Modeling Acute Kidney Injury in Developing Zebrafish
Published on: June 3, 2017
Urinary angiotensinogen as a biomarker for acute to chronic kidney injury transition - prognostic and mechanistic
1Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, U.K.
Insights
Urinary angiotensinogen (uAGT) may predict acute kidney injury (AKI) progression to chronic kidney disease (CKD). This biomarker could indicate renal recovery potential, guiding targeted interventions for kidney disease patients.
Area of Science:
- Nephrology
- Biomarker Discovery
- Renal Medicine
Background:
- Accurate biomarkers for predicting chronic kidney disease (CKD) progression and early detection are currently lacking.
- This deficiency hinders the identification of individuals who could benefit from timely therapeutic interventions.
- Urinary angiotensinogen (uAGT) is investigated as a potential predictive biomarker for kidney disease progression.
Purpose of the Study:
- To evaluate the predictive capability of urinary angiotensinogen (uAGT) in forecasting the transition from acute kidney injury (AKI) to chronic kidney disease (CKD).
- To assess uAGT as a dynamic marker of renal injury and its potential to predict structural recovery post-AKI.
- To explore the clinical utility of uAGT and the potential of early renin-angiotensin system blockade as a therapeutic strategy following AKI.
Main Methods:
- Utilized a murine model of ischemia-reperfusion injury to investigate uAGT's predictive potential.
- Analyzed data from a small prospective study involving patients with biopsy-proven acute tubular necrosis.
- Correlated uAGT levels with the progression of kidney injury and recovery outcomes.
Main Results:
- Findings suggest uAGT serves as a dynamic indicator of renal injury.
- uAGT may predict the likelihood of structural recovery after acute kidney injury.
- The study provides preliminary evidence for uAGT's role in AKI-to-CKD transition prediction.
Conclusions:
- Urinary angiotensinogen (uAGT) shows promise as a biomarker for predicting AKI to CKD progression.
- uAGT may offer insights into renal recovery potential following AKI.
- Further research is warranted to establish the clinical utility of uAGT and explore renin-angiotensin system blockade as a therapeutic target in AKI recovery.
Abstract:
Accurate biomarkers that both predict the progression to, and detect the early stages of chronic kidney disease (CKD) are lacking, resulting in difficulty in identifying individuals who could potentially benefit from targeted intervention. In a recent issue [Clinical Science (2018) 132, 2121-2133], Cui et al. examine the ability of urinary angiotensinogen (uAGT) to predict the progression of acute kidney injury (AKI) to CKD. They principally employ a murine ischaemia reperfusion injury model to study this and provide data from a small prospective study of patients with biopsy proven acute tubular necrosis. The authors suggest that uAGT is a dynamic marker of renal injury that could be used to predict the likelihood of structural recovery following AKI. Here we comment on their findings, exploring the clinical utility of uAGT as a biomarker to predict AKI to CKD transition and perhaps more controversially, to discuss whether the early renin-angiotensin system blockade following AKI represents a therapeutic target.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

